Prospects of using chondroprotectors for the treatment of pulmonary pathology
Background. The complex mechanisms of action of chondroitin sulfate (CS) and glucosamine sulfate (GS) at the molecular level make it possible to assert the applicability of the corresponding drugs far beyond chondroprotection. Inhibition of proinflammatory mechanisms (NF-κB, activation of toll-recep...
Saved in:
Main Authors: | I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2022-01-01
|
Series: | Фармакоэкономика |
Subjects: | |
Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/632 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacoinformation studies of chondroprotectors
by: A. M. Lila, et al.
Published: (2021-10-01) -
Perioperative pharmacotherapy for endoprosthetics: potential of chondroitin sulfate and glucosamine sulfate
by: I. Yu. Torshin, et al.
Published: (2022-04-01) -
Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate
by: I. Yu. Torshin, et al.
Published: (2022-01-01) -
Prospects for the use of chondroitin sulfate and glucosamine sulfate with osteoarthritis associated with pathology of the kidneys and urinary system
by: I. Yu. Torshin, et al.
Published: (2020-04-01) -
Important aspects of osteoarthritis therapy during the COVID-19 pandemic
by: A. M. Lila, et al.
Published: (2022-02-01)